Meta-analysis of the effectiveness and safety of drugs line Magne B6 in gynecology

Abstract

Magnesium deficiency is an important factor in the etiopathogenesis of premenstrual syndrome (PMS) and the cause of complications in patients receiving menopausal hormone therapy (MHT).Materials and methods. The results of a meta-analysis of 8 clinical studies on the use of magnesium preparations in the form of organic salts for oral administration.Conclusions. PMS therapy includes the use of drugs, e.g. magnesium which is associated with a reduction in PMS symptoms: irritability, and emotional lability (5 studies, n=775, OR 0,24, 95% CI 0,20-0,29, p

Keywords

• premenstrual syndrome
• menopausal hormone therapy
• a meta-analysis
• compensation magnesium deficiency
• magne b6
• magne b6 forte